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Introduction {#sec1}
============

Methods to mature human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) may provide considerable advantages to model inherited cardiac diseases in culture ([@bib6], [@bib11], [@bib43]). Early-stage hiPSC-CMs lack discernible T tubules, display rhythmic spontaneous beating with short action potential duration and slow, diffusion-limited calcium influx ([@bib18]). In addition, the contractile machinery of hiPSC-CMs is typically sparse and poorly organized ([@bib9], [@bib12], [@bib18]). Measuring tension remains one of the least characterized aspects of excitation-contraction coupling (ECC), due to the small size and structural immaturity of hiPSC-CMs. Thus, developing methods to measure the contractile properties of hiPSC-CMs and their subcellular organelles, myofibrils, could improve our knowledge of how early-stage cardiomyocytes function during fetal development and at the earliest stages of heart disease.

In multicellular preparations, such as engineered heart tissue constructs, contractile tension of hiPSC-CMs propagates from cell to cell, and tension generation is in the order of micronewtons/section ([@bib39]). However, low cell density, sparse cell-cell coupling, and the compliance of hydrogel- or protein-based scaffolds likely underestimates tension generation and affect contractile kinetics measurements. Single hiPSC-CM tension has been estimated by contraction stress assays ([@bib30]) or atomic force microscopy ([@bib17], [@bib36]) but at dissimilar post-differentiation times. Moreover, two-point force assays detect twitch properties along a single axis and do not include lateral stresses, including friction due to the culture surface. Individual cardiomyocytes cultured on micropost arrays ([@bib31], [@bib32], [@bib44]) can obviate this gap by measuring the tension, velocity, and power of contraction for subcellular bundles of myofibrils at each adhesion point. However, culturing hiPSC-CMs on micropost arrays limits myofibril elongation and bundling, cell morphology maintains a high circularity index, and the resultant tension is the sum of the contraction of unaligned myofibrils developed in multiple directions.

Myofibrils are the smallest subunit of the cardiomyocyte contractile apparatus and consist of sarcomeres (single contractile units) in series. Here we present a method to measure the mechanical properties of single myofibrils isolated from hiPSC-CMs by a fast solution switching method ([@bib4]) that represents a unique tool to assess both steady-state tension and kinetics of contraction and relaxation, independent of the Ca^2+^ handling properties of the cells. The biochemical milieu surrounding myofibrils can easily be controlled experimentally to provide mechanistic insights on actin-myosin cross-bridge cycling and regulation of tension development and relaxation kinetics. Mechanical properties of myofibrils from hiPSC-CMs have not previously been investigated due to their small size and fragility in culture. To overcome this limitation, we developed strategies to drive cardiomyocyte morphology toward an adult phenotype. Single cardiac cells were seeded at low density onto nanopatterned surfaces ([@bib13], [@bib19], [@bib20]) and cultured long term ([@bib18]). This resulted in cell elongation and myofibril bundling, demonstrated by Z bands across the entire cell width and length. Cells had increased myofibril density with evidence of T-tubule formation. We then isolated hiPSC-CM functional myofibrils from nanopatterned cultures to study their contractile properties. We used this system to compare hiPSC-CM myofibrils with those from fetal and adult hearts and to demonstrate impaired myofibril mechanics from a patient-derived line harboring a cardiomyopathic mutation (E848G) in β-myosin heavy chain (*MYH7*).

Results {#sec2}
=======

Engineering hiPSC-CM Morphology {#sec2.1}
-------------------------------

hiPSC-CMs were generated from cells collected either from urine (control~1~) ([@bib10]) or skin fibroblasts (control~2~; FCM) using directed differentiation of high-density monolayers with a combination of activin A and BMP4, along with small molecules that sequentially activate and repress Wnt/β-catenin signaling ([@bib22]) ([Figures 1](#fig1){ref-type="fig"}A and 1B). At 15--20 days post-differentiation (p.d.), single hiPSC-CMs were replated at low density onto fibronectin-coated nanopatterned surfaces fabricated with parallel grooves and ridges of 800 nm width and spacing to promote cell spreading ([@bib13]). Just after replating, 15--20 days p.d. hiPSC-CMs were round-shaped and demonstrated sporadic signs of myofibrillogenesis with sparse expression of sarcomeric elements and assembly in fieri ([Figures 1](#fig1){ref-type="fig"}C and [5](#fig5){ref-type="fig"}A, top). Obtaining mechanical measurements from these pre-myofibrils is quite challenging due to their short length and fragility. Therefore, to achieve myofibril lengths (\>50+ μm) and stability that would enable us to obtain mechanical measurements on our experimental platform, hiPSC-CMs were cultured for an additional 60 days on nanopatterned surfaces (80--100 days p.d. total). This resulted in cells that were elongated ([Figure 1](#fig1){ref-type="fig"}D), and many had dimensions similar to those found for cultured adult cardiomyocytes ([Figure 1](#fig1){ref-type="fig"}E). Cells were rod-shaped with average lengths of 127.3 ± 8.8 μm and average widths of 14.7 ± 0.9 μm. In all hiPSC-CMs, myofibril alignment followed the nanotopographic pattern.

Adult-like Morphology and Dimensions of Later-Stage hiPSC-CMs {#sec2.2}
-------------------------------------------------------------

Later-stage hiPSC-CMs (80--100 days p.d. total; [Figure 1](#fig1){ref-type="fig"}E) were stained for Z bands (anti α-actinin). As observed by phase-contrast imaging ([Figure 2](#fig2){ref-type="fig"}A), quantitative immunocytochemical analysis demonstrated later-stage control-hiPSC-CMs were characterized by aligned myofibrils and clearly defined Z bands spanning the width of the cells. We used fast Fourier transform analysis to quantify the myofibril alignment index based on the regularity of Z bands. Later-stage hiPSC-CMs ([Figure 2](#fig2){ref-type="fig"}) had an extended cell area (control = 7,696 ± 519 μm^2^) and perimeter (control = 291 ± 11 μm) with an elevated index of myofibril alignment (control = 0.014 ± 0.002), indicating a high impact on myofibril organization with this combinatorial approach for cardiomyocyte maturation.

We further investigated the cell structure by staining for caveolin-3 (CAV3), a scaffolding protein of the sarcolemma, which is associated with the formation of caveolae and T tubules during the development of striated muscle ([@bib23]). CAV3 is also implicated in several electromechanical regulation pathways ([@bib8]). Top and side views of confocal images ([Figure 2](#fig2){ref-type="fig"}B) display the organization of cells co-stained for CAV3 and Z bands. In a 3D reconstruction of the confocal images, the cells had a homogeneous distribution of CAV3 over the entire sarcolemma. CAV3 staining revealed finger-like invaginations tightly associated with Z bands, likely representing transverse (T)-tubule-like structures during development ([@bib24]). This finding provides evidence that transverse-axial tubular system (TATS) formation may occur together with myofibrillogenesis and suggests a strict interplay between tubules and Z bands during cardiac development on nanopatterned surfaces.

Isolation of Myofibrils from hiPSC-CMs {#sec2.3}
--------------------------------------

The improved cell morphology and size of later-stage cardiomyocytes cultured on nanopatterned surfaces allowed us to obtain isolated myofibrils with sufficient length and stability for detailed contractile analysis. To isolate myofibrils, we modified a procedure we have commonly used to obtain myofibrils from cardiac tissue. This method is demonstrated in [Figure 3](#fig3){ref-type="fig"}A. We examined two cell skinning approaches to harvest myofibrils: (1) cultured hiPSC-CMs were subjected to pre-treatment with a Rho-associated protein kinase inhibitor (ROCKi) for 1 hr to promote cell detachment and prevent the anoikis phenomena. Cells were subsequently detached by treatment with Versene for 1 hr. hiPSC-CMs were collected from the supernatant and rapidly skinned in rigor solution containing Triton X-100 buffer (1%) for 10 min (skinning in suspension; [Figure 3](#fig3){ref-type="fig"}A (1)). Triton X-100 was then removed by two sequential rinses in normal rigor solution. Versene treatment is gentle and helps to retain intact cell architecture throughout the skinning process. The limiting aspect of this approach is the efficiency of cell detachment, which can affect myofibril density in the final suspension. (2) The second approach consisted of skinning hiPSC-CMs in rigor solution with 1% Triton X-100 applied directly on culture plates for 5 min (skinning on plate; [Figure 3](#fig3){ref-type="fig"}A (2)). The quality of viable myofibrils obtained with the two approaches was indistinguishable, as determined by the morphological and contractile properties, however the yield of myofibrils was substantially greater with the second approach. Thus, we used the second method to obtain isolated single and small bundles of myofibrils ([Figure 3](#fig3){ref-type="fig"}A right) to assess the contractile properties of all hiPSC-CM lines.

Mechanical and Kinetic Properties of Myofibrils from hiPSC-CMs {#sec2.4}
--------------------------------------------------------------

[Figures 3](#fig3){ref-type="fig"}B and [4](#fig4){ref-type="fig"}A illustrate representative tension traces of myofibrils from later-stage hiPSC-CMs maximally activated (15°C) by rapid solution switching, via a double-barreled perfusion pipette, from low Ca^2+^ (pCa9) to high Ca^2+^ (pCa4) ([@bib28]). With activation, tension developed exponentially with a rate constant (*k*~ACT~; [Figures 3](#fig3){ref-type="fig"}D and [4](#fig4){ref-type="fig"}C) that reflects thin filament activation upon Ca^2+^ binding, the rate of strong myosin binding to actin (cross-bridge formation), the subsequent force-generating cross-bridge isomerization and initial cross-bridge turnover. The inverse movement of the perfusion pipette results in rapid Ca^2+^ removal from the solution flow, subsequently resulting in an initial slow, linear phase of relaxation followed by rapid relaxation to baseline tension. During the slow phase of relaxation, force decay occurs under isometric conditions with a rate constant (slow *k*~REL~; [Figure 4](#fig4){ref-type="fig"}C) reflecting the rate of cross-bridge detachment, independent of Ca^2+^ dissociation from troponin C. The subsequent fast monoexponential phase of relaxation (fast *k*~REL~; [Figures 4](#fig4){ref-type="fig"}A and 4C) is associated with sarcomere "give" and reflects inter-sarcomere dynamics ([@bib27]). Maximal and submaximal (pCa5.8) isometric tension and the kinetic properties of myofibrils from hiPSC-CM cell lines were obtained from two healthy adults. Control~1~- and control~2~-hiPSC-CMs were highly comparable in the magnitude and development of maximal tension (*k*~ACT~, pCa4) and relaxation parameters (slow *k*~REL~, slow *t*~REL~, and fast *k*~REL~) ([Table S1](#mmc1){ref-type="supplementary-material"}). Thus, we merged the two datasets for all subsequent comparisons ([Table 1](#tbl1){ref-type="table"}).

In order to characterize myofibril mechanics and kinetics from hiPSC-CMs, we sought to compare these contractile properties with similar measurements from human fetal and adult cardiac myofibrils, reported recently by our group ([@bib3], [@bib25], [@bib28]). [Figure 3](#fig3){ref-type="fig"}C shows representative tension traces from hiPSC-CMs versus fetal (74 days gestational) and adult myofibrils. Isometric tension generation of hiPSC-CM myofibrils was about 6-fold less than adult human ventricular ([@bib25]) or atrial myofibrils ([@bib3]), and about 5-fold less compared with failing human myocardium ([@bib21], [@bib28]). However, myofibril tension was comparable with our recent report on human fetal ventricular myocardium of a similar age ([@bib28]). [Figures 3](#fig3){ref-type="fig"}B and 3C shows that later-stage hiPSC-CM tension (80 days p.d.) closely matches age-related progression of increasing tension of human cardiac tissue in utero. In contrast to tension production, the kinetics of activation and relaxation for hiPSC-CM myofibrils was similar to what we have previously reported for adult and fetal myofibrils ([Figure 3](#fig3){ref-type="fig"}D), indicating related acto-myosin kinetics at this stage. This may be primarily due to all three myofibril groups having β-MHC as the predominant contractile motor isoform (see below). Thus, our data indicate that the magnitude of myofibril tension production is a more valid yardstick for estimating maturation of cardiac myofibrils than parameters of activation and relaxation kinetics. In addition, even though later-stage hiPSC-CMs are beginning to resemble adult cardiomyocyte morphology, our data indicate that the maturation state of individual myofibrils more closely matches gestational development of fetal ventricular muscle.

Modeling Development of Contractile Dysfunction with Familial Cardiomyopathy Mutations {#sec2.5}
--------------------------------------------------------------------------------------

To test the feasibility of using hiPSC-CMs to study the development of contractile abnormalities for disease-associated mutations in sarcomere proteins, we compared age-matched FCM-hiPSC-CMs (FCM) carrying the mutation E848G in β-MHC differentiated and cultured under the same conditions as controls (control-CMs). FCM-hiPSCs were generated from a family showing a unique familial cardiomyopathy that appeared with relatively early onset of arrhythmias, systolic and diastolic dysfunction, without changes in chamber size and wall/septal thickness, suggesting a non-hypertrophic phenotype. Compared with control-CMs, FCMs had increased cell area (p \< 0.01) and cell perimeter (p \< 0.05) ([Figure S1](#mmc1){ref-type="supplementary-material"}). Fast Fourier transform quantitative analysis of the FCM myofibril alignment index indicated myofibril disarray throughout the cytoplasm of some but not all FCMs, compared with consistent control-CM myofibril alignment, presenting a puzzling variability for the FCM cells (p \< 0.01). Despite this dramatic difference in myofibril organization, resting sarcomere length (the distance between Z bands within a myofibril) was comparable with control-CMs (p = 0.71). In addition, the CAV3 expression profile was similar for both cell lines with analogous distribution throughout the sarcolemma ([Figure S2](#mmc1){ref-type="supplementary-material"}).

Representative traces ([Figure 4](#fig4){ref-type="fig"}A) demonstrate marked impairment of maximal isometric tension generation for FCM myofibrils (p \< 0.01; [Figure 4](#fig4){ref-type="fig"}B and [Table 1](#tbl1){ref-type="table"}). We also measured tension at a submaximal Ca^2+^ level (pCa 5.8), closer to where the heart operates. At pCa 5.8, tension generation was approximately half maximal for control-CM myofibrils, but about 0.72 of maximal tension for FCM myofibrils ([Figure 4](#fig4){ref-type="fig"}B and [Table 1](#tbl1){ref-type="table"}). This suggests that FCM myofibrils had increased Ca^2+^ sensitivity of tension development ([Figure 4](#fig4){ref-type="fig"}B), as reported for other hypertrophic cardiomyopathy mutations ([@bib26]).

During maximal activation, *k*~ACT~ was faster (p \< 0.05) for FCM myofibrils ([Figure 4](#fig4){ref-type="fig"}C and [Table 1](#tbl1){ref-type="table"}), suggesting an increased rate of acto-myosin cross-bridge turnover. As expected, at submaximal Ca^2+^ levels, *k*~ACT~ was slower than for maximal (pCa 4.0) activations ([Table 1](#tbl1){ref-type="table"}). However, in contrast to maximal *k*~ACT~ ([Figure 4](#fig4){ref-type="fig"}C and [Table 1](#tbl1){ref-type="table"}), there was no difference in *k*~ACT~ at pCa5.8 (p = 0.83). There were also differences in the relaxation kinetic parameters. Slow *k*~REL~ ([Figure 4](#fig4){ref-type="fig"}C and [Table 1](#tbl1){ref-type="table"}) was faster for FCM myofibrils but the difference was significant only for submaximal activation (pCa4.0, p = 0.25; pCa5.8, p \< 0.05), a finding that supports the hypothesis that the cross-bridge detachment rate is increased ([Figure 4](#fig4){ref-type="fig"}C and [Table 1](#tbl1){ref-type="table"}). The cross-bridge detachment rate is one determinant of the cross-bridge turnover rate, suggesting that the E848G β-MHC mutation may increase cross-bridge turnover by accelerating cross-bridge detachment. This could at least partially explain the lower tension-generating capacity of FCM myofibrils. Finally, there was also a difference in fast *k*~REL~, which was slower for FCM myofibrils during maximal activation (p \< 0.05). This may be a consequence of the increased myofibril Ca^2+^ sensitivity ([@bib15], [@bib35]).

Myofibril Ultrastructural and Proteomics {#sec2.6}
----------------------------------------

Longitudinal sections of single hiPSC-CMs sparsely cultured onto nanopatterned surfaces were analyzed by transmission electron microscopy (TEM). Images of control- and FCM-CMs clearly demonstrate myofibril alignment ([Figure 5](#fig5){ref-type="fig"}A), previously based on Z-band staining ([Figures 2](#fig2){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}). Although morphological analysis by confocal images may suggest adult-like cell characteristics, the ultrastructural architecture of myofibrils demonstrated variable-spaced thick filaments that frequently had a paucity of sarcomeric determinants. Both cell lines expressed I-Z-I bands, although no evidence of H zones was identified ([Figure 5](#fig5){ref-type="fig"}B). In FCM-CMs, the variable phenotype of the sarcomeric ultrastructure appeared more pronounced within cells, with sparse expression of M lines ([Figure 5](#fig5){ref-type="fig"}B).

Western blot analysis of myosin isoform composition indicated a significant amount of β-MHC present in control and FCM myofibrils, suggesting that the myosin isoform switch likely began prior to this stage of maturation ([Figure 5](#fig5){ref-type="fig"}B). This agrees well with our recent report that fetal cardiac myofibrils contain β-myosin predominantly as early as 74 days gestation ([@bib28]), which, in turn, agrees with reports by others ([@bib29]). These data also suggest that differences in contractile kinetics between control and FCM myofibrils were not the result of the myosin isoform, suggesting that they were likely due to the E848G mutation. Troponin I (TNI) isoforms can be used as an indicator of maturation. Early in development, cardiomyocytes express slow skeletal TnI (SSTNI). As maturation proceeds, the cardiac isoform of TNI begins to be expressed and later in development becomes the predominant isoform ([@bib28], [@bib34]). Control- and FCM-CMs expressed both TNI isoforms ([Figure 5](#fig5){ref-type="fig"}C) indicating that the maturation state of the myofibrils was more similar to fetal left ventricular myofibrils than adult (which express CTNI exclusively), consistent with other hiPSC-CMs cultured over time ([@bib1]).

Discussion {#sec3}
==========

In this study, we report that hiPSC-CMs on nanogrooved surfaces in long-term culture can achieve a high degree of structural maturation. Previous reports concluded that T tubules in 2D culture are nearly absent in hiPSC-CMs ([@bib11], [@bib43]). Here, hiPSC-CMs demonstrated clear evidence of a complex architecture that may be associated with forming TATS, and this should be further explored ([@bib33]). TATS is an important hallmark for ECC regulation, with well-aligned Z bands together with composition of elongated myofibrils. We isolated functional myofibrils from these later-stage hiPSC-CMs using a cell skinning method and used a custom-built apparatus ([@bib15], [@bib28]) to measure maximal and submaximal myofibril tension generation that was considerably greater than values from previous reports in intact hiPSC-CMs ([@bib30], [@bib32], [@bib36]). Our values demonstrate weaker force compared with adult cardiac myofibrils but, interestingly, very similar to what we recently reported for human fetal myofibrils of similar gestational age ([@bib28]). Thus, the morphological maturation of later-stage hiPSC-CMs was not matched by maturation of myofibril contractile properties, suggesting that caution should be used when reporting the maturation state by limited analytical criteria.

This study represents a solid step forward in the study of hiPSC-CM development, and it further demonstrates its utility to model the development of disease-related cardiomyocyte contractile dysfunction. First, we may have established features of in vivo gestational maturation in an in vitro model, as indicated from our comparisons with fetal cardiac myofibrils. Second, we may now consider myofibril tension and kinetics of contraction and relaxation as parameters to quantitatively assess maturation state of hiPSC-CM contractile machinery. Others have reported high similarities between hiPSC-CMs and human fetal cardiomyocytes in the gene expression profile ([@bib16], [@bib37], [@bib40]), structural composition ([@bib9], [@bib12], [@bib18]), and electrophysiological and contractile properties ([@bib30]). However, to our knowledge, no other study has quantified the maturation stage of hiPSC-CMs in comparison with fetal cardiomyocyte development. We observed ultrastructural features of sarcomeric units in fieri in which embryonic protein isoforms are still expressed (more SSTNI than CTNI), which may partially explain why the contractile properties resemble those of fetal myofibrils. Sarcomere structural and functional determinants reflected those recently observed in fetal myocardium ([@bib28]) and other (more)-mature hiPSC-CM cell lines ([@bib18]) rather than adult ventricular myofibrils ([@bib3], [@bib28]). Expression of the β-MHC isoform at this stage of maturation explained the similarities in kinetic parameters and that the switch from the α- to β-MHC isoform seen very early in human ventricular myocardial development has already occurred ([@bib28], [@bib29]). Moreover, later-stage hiPSC-CMs had cross-bridge kinetics more representative of ventricular versus atrial myofibrils ([@bib3], [@bib25]), where the rate of cross-bridge turnover is faster due to the presence of α-myosin heavy chain (*MYH6* gene). Since the kinetics are similar between myofibrils from hiPSC-CMs and fetal and adult human ventricle muscle, this suggests that in addition to β-myosin, the light chains may also have changed to the ventricular forms. Future studies to test this hypothesis could include an in-depth analysis of myosin light chain isoform composition, in parallel with heavy chain isoform analysis, as MLC-2v and -2a have been previously proposed as markers for ventricular and atrial differentiation, respectively ([@bib1]). This may suggest that hiPSC-CMs matured in our conditions develop myofibrils that favor the ventricular rather than the atrial contractile phenotype ([@bib1]). Thus, myofibril mechanics and kinetic properties may be useful for evaluating the composition of cardiac ventricular versus atrial populations following differentiation, while myofibril contractile properties and sarcomere protein composition may be used as a yardstick for functional maturation that has previously been based primarily on action potential profiles. Our results also point to a note of caution. Despite a misleading adult-like morphology observed by confocal microscopy, the hiPSC-CMs in our study should be considered more as fetal cardiomyocytes in their fine structure and functional capacity, and not be considered as recapitulating the adult cardiomyocyte phenotype.

Since hiPSC-CMs can mature in vitro over time in culture ([@bib18]), they may prove valuable for investigating the developmental time course of early-stage cardiac diseases, representing a unique platform to predict adverse prenatal outcomes and to develop therapies. We reported FCM hiPSC-CMs carrying the E848G- β-MHC mutation had similar maturation in terms of T-tubule formation but abnormalities at the myofibril level. Myofibril disarray has been described for other *MYH7* mutations and can result from variable expression of mutated and wild-type myosin in individual myocytes, as previously proposed ([@bib14]). Force decrements result from several *MYH7* mutations ([@bib41]) and could be due to cardiomyocyte and/or myofibril disarray. Here we demonstrated that, at the individual myofibril level, there is also a force deficit with the E848G β-MHC mutation, which in addition to likely myofibril structural alterations, may be partially due to an accelerated cross-bridge detachment. A pathway similar to the latter was previously suggested for myofibrils from one patient carrying the R403Q β-MHC mutation associated with hypertrophic cardiomyopathy (HCM) ([@bib2]). For the R403Q mutation, an increased cross-bridge detachment rate was related to an increased cost of tension generation ([@bib42]) and reduced force-generating capacity ([@bib7]). In addition, the development of the sarcomere structure may be delayed or altered during maturation by disease-associated mutations.

Notably, increased Ca^2+^ sensitivity and altered cross-bridge kinetics have been reported as hallmarks of human adult myocardium expressing several *MYH7* mutations ([@bib2], [@bib42]). However, in the FCM cell line, structural variability may lead to different amounts of β-myosin heavy chain (and/or total myosin) incorporated into forming myofibrils during maturation, contributing to additional contractile deficits. As a feedback mechanism, weaker tension-generating myofibrils during mechanical loading may lead to cellular hypertrophy during development. We were limited in our ability to quantify sarcomere protein content and concentration in this study, due to the limited amount of the frozen remains of the same myofibril preparations used for the mechanical experiments. Future studies will focus more on documenting the absolute amount of troponin or the relative abundance of SSTNI versus CTNI, as this may affect myofibril Ca^2+^ sensitivity and troponin complex activation ([@bib15]), even if the kinetics of force development or relaxation may be not influenced by the TnI isoform switch ([@bib5]).

In conclusion, we were able to assess the structure and function of myofibrils from hiPSC-CMs at a relatively advanced state of maturation, and compared them with properties previously reported for myofibrils from human fetal ventricular muscle. That said, much work remains to be done. We report on only a single time point, thus have not established a developmental time course. In addition, it would be interesting to see if maturation could be further progressed with a longer time in culture or via application of biological molecules such as T3, Let-7 ([@bib16], [@bib44]), or other transcriptional and maturation regulators, or with other environmental conditions such as electrical stimulation and/or varying load. Future studies should also provide more complete and detailed proteomic information regarding the time course of protein isoform appearance, disappearance, stoichiometry of proteins incorporated into myofibrils and post-translational modifications. We have also demonstrated the utility of this approach to study the influence of disease-associated mutations on myofibril structure and function. However, this is just one example of the potential of the approach that can not only be compared with normal development, but also with a myriad of other disease-associated mutations. Finally, while we have provided initial evidence that T-tubule formation may be initiated under our conditions, future studies are needed to verify and extend these results, which may be important for disease studies where calcium handling properties may also be affected and coupled with myofibril dysfunction. Importantly, our approach provides a platform to investigate the earliest stages of disease development resulting from alterations in myofibril properties.

Experimental Procedures {#sec4}
=======================

An expanded version of the Experimental Procedures appears in the [Supplemental Information](#app2){ref-type="sec"}.

Human Subjects {#sec4.1}
--------------

Protocols for this study were approved by the Institutional Review Board of the University of Washington. Written consent was obtained from all study participants.

Human Pluripotent Stem Cell Culture and Cardiac Differentiation {#sec4.2}
---------------------------------------------------------------

Patient-derived cardiomyocytes were differentiated from two healthy volunteers, control~1~ hiPSC line generated from urine and control~2~ from skin fibroblasts of healthy patients as well as for the FCM patient hiPSC lines as previously described ([@bib10]). The cardiac myocyte differentiation protocol is described in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Fabrication and Cell Maturation onto a Nanopatterned Substratum {#sec4.3}
---------------------------------------------------------------

Anisotropically nanofabricated substrata (ANFS) were fabricated using a capillary force lithography procedure as previously described ([@bib13], [@bib19]). Further details are given in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Cell Morphology, Myofibril Structural, and Protein Analysis {#sec4.4}
-----------------------------------------------------------

Long-term cultured hiPSC-CM onto nanopatterned surfaces were washed with PBS and in succession fixed with 4% paraformaldehyde, and morphological characteristics were assessed by confocal microscopy. Myofibril structure was assessed by TEM. Sarcomeric protein composition was studied by SDS-PAGE and western blot analysis using frozen remains of myofibril preparations. Details are provided in the [Supplement Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Myofibrils {#sec4.5}
----------

Myofibrils were isolated using two separate approaches. One approach provided a greater yield so was used for the majority of experiments. Myofibrils were mounted in a custom-built apparatus, and the mechanical properties measured as previously described ([@bib4], [@bib21], [@bib28], [@bib38]). Details are provided in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Statistical Analysis {#sec4.6}
--------------------

Data are reported as means ± SEM. Student\'s two-tailed t test was used with statistical significance in control- and FCM-hiPSC-CM lines set at ^∗^p \< 0.05 and ^∗∗^p \< 0.01. For controls comparison, one-way ANOVA with a Tukey post hoc test was used with statistical significance set at p \< 0.05. The number of independent experiments (N) performed was more than three for each analysis. For myofibril mechanics analysis, n = number of myofibrils.

Author Contributions {#sec5}
====================

All experiments were performed at the University of Washington in Seattle, WA, USA. J.M.P. designed the method, performed cell differentiation and all experiments, analyzed and interpreted data, and wrote the manuscript. A.W.R. contributed to the myofibril experiments. J.M.K. performed the proteomic assays. K.C.Y. generated the FCM cell line. X.G., D.L.M., and M.K.C. generated and provided the UC 3-4 cell line. L.P. provided training on hiPSC differentiation and control~2~ cell line. V.M. performed confocal imaging. R.Z. contributed to the cell cultures. J.M. fabricated the ANFS and provided assistance with cell plating. M.Y.J contributed to the design of the myofibril isolation protocol. D.H.K. provided the ANFS. C.P. and C.T. contributed to the design of the myofibril isolation protocol and interpretation of the results. C.E.M. contributed to the overall study design, and provided cells and training assistance. M.R. contributed to the overall study design, interpretation of the results, and writing of the manuscript. All authors critically reviewed the manuscript and approved the final version of this manuscript for publication.
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![Protocol for Cardiac Maturation of Human Pluripotent Stem Cells on Nanopatterned Surfaces in Long-Term Cultures\
(A--E) Phase-contrast images of hiPSCs at different stages of differentiation and cardiac maturation. (A) hiPSC passaging before differentiation. (B) At day 0, hiPSCs were differentiated into cardiomyocytes with a monolayer-directed differentiation protocol. Beating areas were visible from day 8 post-differentiation (p.d.). (C) At 15 p.d, single hiPSC-CMs were replated onto nanopatterned surfaces until day 80--100 in low density for cardiac maturation. Early-stage hiPSC-CMs were round-shaped and lacked of aligned myofibrils. (D) After replating, hiPSC-CMs showed early progressive elongation and increased myofibril density/alignment. (E) Later-stage hiPSC-CMs were rod-shaped and myofibrils were highly aligned. These cells had length of 127.3 ± 8.8 μm and width of 14.7 ± 0.9 μm (n = 44 from controls). Scale bars in (A) and (B) represent 200 μm; scale bars in (C), (D), and (E) represent 20 μm.](gr1){#fig1}

![Later-Stage hiPSC-CMs Grown on a Nanopatterned Surface Promote Myofibril Alignment and T-Tubule Formation\
(A) Confocal images of later-stage hiPSC-CMs grown on nanopatterned surfaces. Cells were stained for Z bands (α-actinin, red) and for nuclei (DAPI, blue). hiPSC-CMs exhibited mature morphology with rod-shaped, aligned myofibrils and clearly defined Z bands (enlargement of the area within the white rectangle) as quantified by fast Fourier transform (FFT) analysis.\
(B) Confocal images of hiPSC-CMs stained with antibody against caveolin-3 (green), α actinin (red), and nuclei (blue). Top: hiPSC-CMs displayed development of a transverse-axial tubular system (TATS), with both transverse and axial elements. Bottom: representative 3D picture of TATS in hiPSC-CMs. Arrowheads in the 3D reconstruction highlight transverse tubular elements (green), running in parallel to a Z line (red). Axial tubules occurred perpendicularly to the Z lines and were evident in the side view. Scale bars represent 20 μm.](gr2){#fig2}

![Isolation, Tension Generation, and Kinetic Properties of hiPSC-CM Myofibrils\
(A) Scheme for the isolation of myofibrils from hiPSC-CMs. Two skinning approaches were developed. (1) Skinning in suspension: myofibril density in the final suspension was variable and limited by the efficiency of cell detachment. (2) Skinning on plate: myofibril density in the final suspension was significantly higher. Right: representative phase-contrast images of a thin bundle of myofibrils from hiPSC-CMs, collected with the latter method at different magnifications. Myofibrils were mounted between the tip of a length controller (left) and a calibrated cantilever (right) in a custom-built apparatus. Myofibril mechanics and kinetics were measured by fast solution switching.\
(B) Representative traces of tension generation of hiPSC-CM (blue), human ventricular fetal (fetal, gray) and adult (black) myofibrils maximally activated. Compared with adult, both fetal and hiPSC-CM myofibril isometric maximal tension (pCa 4.0) was weaker.\
(C) Dashed line represents the line fit to the data (N \> 3 and n = 4--40 per condition) from [@bib28] of how tension-generating capacity developed with increasing gestational age of human fetal ventricular samples ([@bib28]). hiPSC-CM (80 days p.d., blue) myofibrils generated the same maximal tension as those of human fetal ventricle at a similar gestational age (74 days gestation, gray).\
(D) Following Ca^2+^ application, force developed exponentially with a rate constant (*k*~ACT~) that reflects the cross-bridge turnover rate. In hiPSC-CM myofibrils, kinetics of activation were in the same order of magnitude. Data from human fetal and adult cardiac myofibrils are reported in [@bib28]. Experimental conditions: 15°C; pCa relaxing and activating solution, 9.0 and 4.0, respectively.](gr3){#fig3}

![Tension Generation and Kinetic Properties of Control and FCM-hiPSC-CM Myofibrils\
(A) Representative traces of tension generation of control (blue) and FCM-CM (red) myofibrils maximally activated and fully relaxed by the fast solution switching method.\
(B) Compared with controls, FCM-CMs myofibril isometric maximal tension (pCa 4.0) is impaired. At submaximal Ca^2+^ level (pCa 5.8), tension generation was reduced 50% in control but only 28% in FCM, indicating increased Ca^2+^ sensitivity of tension development (N \> 3 and n = 15--26 per condition).\
(C) Left: following Ca^2+^ application, tension develops exponentially with a rate constant (*k*~ACT~). Right: the reversed movement of the pipette induced biphasic relaxation. In the slow linear phase (rate, slow *k*~REL~ and duration slow t~REL~), force decay occurred under isometric conditions and in the absence of Ca^2+^. The fast exponential phase (rate, fast *k*~REL~) follows sarcomere "give" and reflects inter-sarcomere dynamics. FCM-CM myofibrils exhibited faster *k*~ACT~, indicating an accelerated cross-bridge turnover rate. Slow *k*~REL~ was faster with no difference in slow t~REL~. The fast monoexponential phase of relaxation (fast *k*~REL~) was slower.\
Averages in (B) are reported as means ± SEM; data shown refer to [Table 1](#tbl1){ref-type="table"}; ^∗∗^p \< 0.01; NS not significant estimated by Student's t test.](gr4){#fig4}

![Ultrastructural Organization and Proteomics of Later-Stage hiPSC-CMs on Nanopatterned Surfaces Reveal Immature Sarcomeric Composition\
Single cells in sparse cultures on nanopatterned surfaces were investigated for sarcomeric ultrastructures.\
(A) Transmission electron microscopy (TEM) images of early-stage (control~1~), later-stage (control~1~), and FCM-hiPSC-CMs (FCM-CMs) at low magnification (12,000×) show the presence of aligned myofibrils. Early stages look quite immature with contractile machinery forming but early occurrence of myofibril alignment. Later stages (both control and FCM-CMs) were more mature showing bundling of Z bands (arrowheads).\
(B) TEM images acquired at higher magnification (40,000×) confirm a clear alignment of Z disks (arrowheads), but variable-spaced thick filaments remarkably visible in FCM-hiPSC-CMs with evidence of myofibril disarray in some cases. Both later-stage cell lines expressed I-Z-I bands with no clear evidence of H zones. In FCM-CMs, the sarcomeric ultrastructure was highly variable with sparse expression of M lines (stars).\
(C) Proteomics of later-stage hiPSC-CMs (100 days p.d.) were compared with fetal left ventricular (LV) samples (130 gestational days). β-myosin was predominant at this stage of maturation indicating α to β isoform switch has occurred. CTNI expression indicated a higher grade of maturation. However, SSTNI was still expressed, confirming immature phenotype as seen for fetal LV. Representative western blot images were cropped. Scale bars represent 1 μm for the overview and 500 nm for the detailed view.](gr5){#fig5}

###### 

Summary of Mechanical and Kinetic Properties of Myofibrils From hiPSC-CMs Following Maximal and Submaximal Ca^2+^ Activation

  Myofibril Type[a](#tblfn1){ref-type="table-fn"}   Tension (mN/mm^2^)[b](#tblfn2){ref-type="table-fn"}   *k*~ACT~ (s^−1^)[c](#tblfn3){ref-type="table-fn"}   *k*~REL~, Slow (s^−1^)[d](#tblfn4){ref-type="table-fn"}   *t*~REL~, Slow (ms)[e](#tblfn5){ref-type="table-fn"}   *k*~REL~, Fast (s^−1^)[f](#tblfn6){ref-type="table-fn"}
  ------------------------------------------------- ----------------------------------------------------- --------------------------------------------------- --------------------------------------------------------- ------------------------------------------------------ ---------------------------------------------------------
  **pCa 4.0**[g](#tblfn7){ref-type="table-fn"}                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                               
  Control (n)                                       18.6 ± 2.5 (26)                                       0.51 ± 0.04 (23)                                    0.30 ± 0.04 (25)                                          192 ± 7.4 (29)                                         2.66 ± 0.3 (25)
  FCM (n)                                           8.2 ± 1.4 (15)^∗∗^                                    0.83 ± 0.13 (14)^∗^                                 0.37 ± 0.09 (13)                                          191 ± 21 (13)                                          1.69 ± 0.3 (15)^∗^
                                                                                                                                                                                                                                                                               
  **pCa 5.8**[h](#tblfn8){ref-type="table-fn"}                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                               
  Control (n)                                       8.5 ± 1.4 (22)                                        0.39 ± 0.06 (22)                                    0.30 ± 0.03 (17)                                          154 ± 7.9 (21)                                         2.47 ± 0.4 (22)
  FCM (n)                                           5.9 ± 1.3 (14)                                        0.40 ± 0.04 (13)                                    0.58 ± 0.12 (15)^∗^                                       186 ± 17 (14)                                          2.07 ± 0.4 (15)

^∗^p \< 0.05; ^∗∗^p \< 0.01; estimated by Student's t test.

Data are means ± SEM. For the comparison with FCM myofibrils, control~1~ and control~2~ data were merged. N = 3 for each condition.

Tension, maximal, and submaximal Ca^2+^-activated tension.

Rate of force generation following Ca^2+^-activation.

Slow, rate of the slow isometric phase of relaxation estimated from the normalized slope of the linear fit to the force trace.

Slow, duration of the slow isometric phase of relaxation following sudden Ca^2+^ removal.

Fast, rate of the fast phase of relaxation estimated from the time constant of the exponential fit to the force trace.

Maximal activating solution.

Submaximal activating solution.
